Top Markets
Coin of the day
MabCure Inc. MabCure Inc.

MabCure Inc.

MBCI
Clasificación en acciones #41405
MabCure Inc., a development stage company, engages in developing and... MabCure Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer. It owns a proprietary technology for the generation of monoclonal antibodies against desired antigens, such as cancer markers. The company was formerly known as Smartec Holdings, Inc. and changed its name to MabCure Inc. in January 2008 to reflect its new business plan. MabCure Inc. was founded in 2006 and is based in White Plains, New York.
Precio por acción
$0.0003
Última sincronización: 2026-08-11
Capitalización bursátil
$21.97K
Cambio (1 día)
0.00%
Cambio (1 año)
200.00%
País
US
Comercio MabCure Inc. (MBCI)

Categoría

Historial del precio de la acción de MabCure Inc. (MBCI)
Precio más alto de cierre: $0.00 el 2026-08-01

Precio más bajo de cierre: $1.01 el 2007-12-01
Historial del precio de la acción de MabCure Inc. desde 2007 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) 0.00%
2025 118.18%
2024 -66.67%
2023 -67.86%
2022 -77.94%
2021 91.39%
2020 243.41%
2019 -68.10%
2018 -32.65%
2017 14.91%
2016 75.25%
2015 -27.57%
2014 -62.58%
2013 -56.22%
2012 -85.27%
2011 -83.42%
2010 -14.01%
2009 -40.28%
2008 -0.99%
2007 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$59.08 62.03%
US
$49.82 72.68%
SE
$183.38 42.53%
FR
$62.57 5.21%
IT
$113.04 55.27%
US